What do all of these cases have in common? Therapeutic success, patient satisfaction and drugs being used off-label for treating conditions they have no official indication for.
We surveyed the Medical Post audience to better understand where and how they get fresh medical information, whether it be a quick update on a new drug indication, or sharing wisdom with peers in-person.
May 30 is World MS Day. I’d like to take the opportunity to discuss the importance of pharmacogenomics in providing complete care for patients with multiple sclerosis.
Conservatives say the federal government is offering ‘false hope’ to Canadians with a national pharmacare bill that will not initially apply to a broad range of medications.